Evidence map›Paper›PMID 38092668›Full record

ArticleMicrobiology spectrum2024

Combined usage of serodiagnosis and O antigen typing to isolate Shiga toxin-producing

Kenichi Lee, Atsushi Iguchi, Chikako Terano, Hiroshi Hataya, Junko Isobe, Kazuko Seto, Nozomi Ishijima, Yukihiro Akeda, Makoto Ohnishi, Sunao Iyoda and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Shiga Toxin-ProducingMicroorganisms · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kenichi LeeDepartment of Bacteriology I, National Institute of Infectious Diseases , Tokyo, Japan.ORCID 0000-0002-4765-0989
Atsushi IguchiDepartment of Animal and Grassland Sciences, Faculty of Agriculture, University of Miyazaki , Miyazaki, Japan.ORCID 0000-0003-3826-7520
Chikako TeranoDepartment of Nephrology and Rheumatology, Tokyo Metropolitan Children's Medical Center , Tokyo, Japan.
Hiroshi HatayaDepartment of Nephrology and Rheumatology, Tokyo Metropolitan Children's Medical Center , Tokyo, Japan.
Junko IsobeDepartment of Bacteriology, Toyama Institute of Health , Imizu, Toyama, Japan.
Kazuko SetoDepartment of Bacteriology I, National Institute of Infectious Diseases , Tokyo, Japan.
Nozomi IshijimaDepartment of Bacteriology I, National Institute of Infectious Diseases , Tokyo, Japan.
Yukihiro AkedaDepartment of Bacteriology I, National Institute of Infectious Diseases , Tokyo, Japan.
Makoto OhnishiDepartment of Bacteriology I, National Institute of Infectious Diseases , Tokyo, Japan.
Sunao IyodaDepartment of Bacteriology I, National Institute of Infectious Diseases , Tokyo, Japan.
EHEC Working Group in Japan

Funding

Japan Agency for Medical Research and Development (AMED) JP22fk0108611MEXT | Japan Society for the Promotion of Science (JSPS) 18K15156, 20K07506, 21K07017Ministry of Health, Labour and Welfare (MHLW) JPMH21HA1001, JPMH 20KA0501, JPMH 20KA3002
6 · The paper itself

Abstract

importanceHemolytic uremic syndrome (HUS) is a life-threatening disease caused by Shiga toxin-producing

Indexed as

Escherichia coli InfectionsHemolytic-Uremic SyndromeShiga-Toxigenic Escherichia coliGenomicsHumansO AntigensSerologic TestsSerotypingShiga ToxinO AntigensShiga Toxingenome analysishemolytic uremic syndromeimmunomagnetic separationimmunoserologyShiga toxin-producing Escherichia coli

Identifiers

PMID38092668
PMCPMC10790564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.